Philips highlights AI-powered solutions focus to realize precision
diagnosis at RSNA 2019
December 1, 2019
Chicago, U.S. and Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, today revealed its industry-leading enterprise imaging
portfolio comprising innovative digital imaging platforms, advanced
informatics and a suite of services at the 2019 Radiological
Society of North America Annual Meeting (RSNA). With a focus on
optimizing image acquisition, viewing and data interpretation, and
diagnostic patient management workflows, Philips is providing
flexible and scalable enterprise imaging solutions to hospitals and
imaging centers as they seek to step up their performance by
simultaneously improving the patient experience, health outcomes,
and staff experience, while lowering the cost of care.
With comprehensive enterprise imaging capabilities at its
foundation, at RSNA Philips is harnessing the power of AI to create
insights from the complete range of patient data, including
pathology and genomics. Combining simplified workflows, strong
clinical capabilities and AI, Philips’ patient-centered approach
empowers healthcare providers to provide a precision diagnosis,
leading to targeted therapies with predictable outcomes.
“Philips has significantly extended its enterprise imaging
portfolio through strategic investments in R&D and
complementary acquisitions, all guided by the goal of enabling
precision diagnosis,” said Rob Cascella, Chief Business Leader for
Precision Diagnosis at Royal Philips. “From capabilities in data
integration and AI to completely renewed platforms across MRI and
CT, our portfolio and our ability to shape solutions to meet
healthcare providers’ needs is stronger than ever.”
Workflow innovations key to improving the experience of
staff and patients Recent research commissioned by Philips
highlights the need for radiology staff empowerment and
workflow-focused innovation. With pressure on imaging departments
mounting amid rising patient volumes and a global shortage of
qualified staff, improvements in workflow and efficiency, supported
by data integration and AI, can improve the experience of staff and
patients and, more broadly, enhance clinical outcomes while
reducing costs. From reducing MR exam times by up to 50% [1] to
reducing the number of steps that a clinician needs to take for a
3D vascular ultrasound assessment from 10 to one [2], Philips is
supporting improved workflow across its portfolio.
Introducing Philips’ next-generation enterprise imaging
informatics solutionAt RSNA Philips is launching its
next-generation enterprise imaging informatics solution. The
introduction follows several years of strategic investments in
R&D, AI and complementary acquisitions, resulting in a suite of
integrated products that deliver a comprehensive platform designed
to connect clinical capabilities and optimize workflows around
every step in the patient’s journey.
Philips is also launching IntelliSpace AI Workflow
Suite [3], which enables healthcare providers
to seamlessly integrate AI applications into the imaging workflow.
Part of Philips’ new enterprise imaging informatics solution, the
comprehensive AI workflow suite provides a full set of applications
for integration and centralized workflow management of AI
algorithms, delivering structured results wherever they’re needed
across the healthcare enterprise.
New Computed Tomography platformsNow available
in North America, the Incisive CT integrates innovations in
imaging, workflow, and lifecycle management, helping healthcare
providers to improve the Computed Tomography (CT) experience for
patients and staff, enabling smart clinical decision-making and
increasing efficiency. With its industry-first ‘Tube for Life’
guarantee [4], Philips will replace the Incisive’s X-ray tube – a
key component of any CT system – at no additional cost throughout
the entire life of the system, potentially lowering operating
expenses by an estimated $420,000 [5]. The system also enables
inter-operator consistency, increases uptime and decreases ‘time to
results’ by 19% [6].
At RSNA, Philips is launching the CT 6000 iCT and the CT 5000
Ingenuity. The innovative new platforms offer new capabilities
including advanced workflow benefits, cybersecurity and safeguards
– as well as software and hardware improvements that enhance
performance and reliability. The company will also be highlighting
the IQon Elite Spectral CT, the world's first spectral
detector-based CT system.
Demonstrating innovation leadership in MRWith
improving MR speed and workflow a key area of attention for imaging
providers, Philips recently marked the completion of its one
millionth patient scan accelerated with Compressed SENSE, an
advanced solution that reduces exam times up to 50% [7]. Combining
powerfully with Compressed SENSE, Philips’ latest workflow
solutions integrate guided patient setup and scanning automation,
along with AI-embedded technology including VitalEye, VitalScreen
and SmartExam [8], helping to save time and staff stress by
simplifying the number of workflow steps.
At RSNA, Philips is also highlighting its Ambition 1.5T MR
platform, the industry’s first and only commercially available
fully sealed magnet for more productive, helium-free operations
[9]. Since its launch last year, the breakthrough platform with its
fully-sealed BlueSeal magnet has received an enthusiastic reception
from healthcare providers worldwide, reducing the chance of
potentially lengthy and costly disruptions, and virtually
eliminating dependency on a commodity with an unpredictable
supply.
Focus on quality and efficiency in digital
radiographyLaunching at RSNA, the new release of the
MobileDiagnost wDR [10] is a premium mobile digital radiography
system that brings the superb image quality and high efficiency of
Philips’ premium mounted systems to a mobile system. The
MobileDiagnost wDR comes with the Philips Eleva user interface, a
common platform across a range of Philips digital radiography
systems that’s easy-to-learn and customizable to allow a smooth and
efficient, patient-focused workflow. The system also includes a
range of security and access management features, workflow
enhancements, and Philips' UNIQUE 2 image processing, which
provides superb images of all anatomical areas.
Improving clinical confidence and the patient experience
in ultrasoundOn show for the first time at RSNA, the EPIQ
Elite ultrasound system is a new premium ultrasound that combines
the latest advances in transducer innovation and enhanced
performance to improve clinical confidence and the patient
experience. EPIQ Elite offers a range of diagnostic ultrasound
solutions tailored to the needs of specific medical specialties,
including Philips’ first solution for vascular assessment and
diagnosis. The Philips Ultimate Ultrasound Solution for Vascular
Assessment combines 3D and 4D imaging, a breakthrough simplified
workflow and complimentary clinical tools to effectively assess and
monitor vascular disease.
End-to-end solutions for oncologyAt RSNA
Philips is also highlighting its IntelliSpace Precision
Medicine oncology solutions portfolio, which drives diagnostics and
therapy selection for clinical, operational and financial
improvements through Oncology Pathways powered by Dana-Farber
Cancer Institute, clinical trial matching and multi-disciplinary
tumour board solutions. The company is also showcasing its
integrated radiation oncology portfolio, including IntelliSpace
Radiation Oncology [11], an intelligent patient management solution
to manage complexity, improve efficiency and enable operational
excellence in radiotherapy departments.
Philips’ Vereos Digital PET/CT, the world’s first and only fully
digital, clinically proven PET/CT solution. It is supported by
rigorous clinical evidence, including more than four years of
investigational studies and over 100 published clinical
studies.
A new standard for the future of image-guided procedures
with Azurion with FlexArmDuring increasingly complex
interventions, clinicians need to quickly and easily visualize
critical anatomy and identify changes to the patient during the
procedure. Azurion with FlexArm includes a set of innovations that
makes it easier for the clinician to perform imaging across the
whole patient in both 2D and 3D. As the clinician moves the system,
the image beam automatically maintains alignment with the patient,
allowing more consistent visualization and enabling them to keep
their focus on the treatment. Launched in February 2017, Philips’
advanced Azurion platform for image-guided therapy has already been
used to treat more than one million patients [12].
The range of diseases that can be treated with minimally
invasive procedures continues to expand. In the run-up to RSNA,
Philips announced a major multicenter clinical trial to assess the
impact of a ‘Direct to Angio Suite’ workflow on stroke patient
outcomes. The trial will be carried out primarily on Philips
Azurion, the company’s leading platform for interventional
procedures.
Transforming people’s healthcare experiences through
designThroughout its booth, Philips will also be
highlighting its healthcare experience design capabilities.
Philips’ evidence-based research approach and people-centric design
thinking help facilities uncover new opportunities to improve the
patient, family and staff experience. With over 1500 installations
worldwide, Ambient Experience solutions can benefit many areas –
from waiting areas and uptake rooms to procedure and recovery rooms
and even entire departments.
Driving the transition to a circular
economyPhilips is highlighting its efforts to transition
to a ‘circular economy’ in healthcare. The company is on track to
deliver on its 2018 pledge to take back and repurpose all the large
medical systems equipment that its customers are prepared to return
to it by 2020. The company is actively pursuing the trade-in of
equipment such as MRI, CT, ultrasound and interventional and
diagnostic X-ray systems, taking full control to ensure that all
traded-in materials are repurposed or recycled in a responsible
way. An important part of its efforts is the company’s Diamond
Select refurbished systems program, which provides refurbished
imaging systems that have the same Philips quality and performance
as new equipment at lower cost.
Discover more about Philips at RSNA 2019Philips
will demonstrate its integrated portfolio of imaging solutions at
RSNA 2019 in booth #6730. In addition, Philips will also be
highlighting its AI capabilities as part of the AI showcase (booth
#10109).
On its main stand, Philips will host an engaging program of
talks by healthcare providers and Philips executives. In addition,
the company will host three presentations during the event:
- “From insights to action: leveraging AI end-to-end in
radiology” – Sham Sokka, Marketing Leader for Precision
Diagnosis at Philips, taking place 14:30-14:50, Monday December 2
at the Innovation Theater
- “Creating winning workflows: identifying pain points
and solutions within radiology workflow” – Cree Gaskin MD
(UVA Health) and Jans Boerggraf MD (University of Cologne),
moderated by Chip Truwit, Chief Medical Officer, Diagnostic Imaging
at Philips, taking place 09:00-10:30, Tuesday December 3 in CS31,
room S101AB
- “ED radiology exam wait time prediction” –
Jacob Kazam MD and Keith Hentel MD (NYP), taking place 12:00-12:20,
Thursday December 5 at the AI Theater
For more Philips news from RSNA click here and follow
@PhilipsLiveFrom for #RSNA19 live updates.
[1] Using Compressed SENSE technology and compared to Philips
exams without Compressed SENSE.[2] Report: EPIQ Ultrasound
Marketing Claims Evaluation Study, September 10, 2018, Philips.[3]
IntelliSpace AI Workflow Suite is not intended for diagnosis or
treatment selection. Work in progress, not available for sale.[4]
Life of the product is defined by Philips as 10 years. Tube for
Life guarantee availability varies by country. Please contact your
local Philips sales representative for details. [5] Actual
operating costs for customers vary significantly because many
variables exist (such as CT make and model, hospital/imaging center
size, case mix, system usage). The potential savings identified
estimates the avoidance of purchasing replacement tubes over a
10-year useful life of a CT system, based on an average selling
price of $140,000 per replacement tube and estimated tube life of 3
years. There can be no guarantee that all customers will achieve
this result. Tube for Life guarantee availability varies by
country.[6] Based on a study performed at Oz Radiology Group.
Results from case studies are not predictive of results in other
cases. Results in other cases may vary.[7] Using Compressed SENSE
technology and compared to Philips exams without Compressed
SENSE.[8] SmartExam is not available to patients with MR
Conditional Implants.[9] The Ambition 1.5T MR contains less than
0.5% of the helium of a conventional system and this is permanently
sealed inside the device.[10] The MobileDiagnost wDR is available
for sale in the USA and worldwide.[11] IntelliSpace Radiation
Oncology is considered works in progress and are not available for
sale.[12] More than one million procedures have been performed on
Philips Azurion based on Philips’ internal case and procedure
data.
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel.: +31 631 639
916Email: mark.groves@philips.comTwitter: @mark_groves
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2018
sales of EUR 18.1 billion and employs approximately 80,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Philips_CT_5000_Ingenuity
- Philips_VitalEye_MR_technology
- IntelliSpace_AI_Workflow_Suite
- Philips_Clinical_Informatics
- Philips_CT_6000_iCT
- Philips_EPIQ_Elite_vascular_assessment_cartoid_artery
- Philips_MobileDiagnost_wDR_2.2
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2024 to May 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From May 2023 to May 2024